MENLO PARK, Calif., July 28, 2015 /PRNewswire/ -- BioPharmX Corporation (NYSE MKT: BPMX) today announced that its product to address premenstrual breast discomfort, Violet® iodine, will soon be available through a wholly owned subsidiary of The Kroger Co. (NYSE: KR), the largest U.S. grocery retailer.
The product will make its retail grocery debut in upscale Harris Teeter, a wholly owned subsidiary of The Kroger Co., which operates 235 stores in eight states and the District of Columbia.
This expansion reflects the vision of the company to offer Violet iodine to consumers where they live and shop. BioPharmX is expanding distribution methodically by rolling out to regional grocers to offer the first-of-its-kind product to alleviate premenstrual breast discomfort.
"The Violet woman finds herself already shopping in grocery stores for personal hygiene and wellness products," said Anja Krammer, President of BioPharmX. "Making Violet available in select grocers where she already purchases everyday essentials for her family just makes sense. This expansion is a natural next step in distribution for the company."
Violet iodine is expected to be available for purchase in all 235 Harris Teeter stores by September 2015.
About Violet® iodine Violet iodine is a daily iodine supplement for the relief of the most common symptoms of cyclic mastalgia and fibrocystic breast condition (FBC), including monthly swelling, tenderness, aches and heaviness. Violet iodine is available for sale at select CVS Pharmacies and The Vitamin Shoppe and online at cvs.com, vitaminshoppe.com, drugstore.com, and walgreens.com. To learn more about Violet iodine, visit www.VioletDaily.com and follow us on Facebook, Twitter, and Instagram.
About BioPharmX™ Corporation BioPharmX™ Corporation (NYSE MKT: BPMX) is a Silicon Valley-based specialty pharmaceutical company, which seeks to provide products through proprietary platform technologies for prescription, over-the-counter ("OTC"), and supplement applications in the health and wellness markets, including women's health and dermatology. To learn more about BioPharmX, visit www.BioPharmX.com.
SOURCE BioPharmX Corporation